Palmitoyl Pentapeptide-4 Reconstitution: Step-by-Step Laboratory Guide

Palmitoyl Pentapeptide-4 (Pal-KTTKS, Matrixyl, N-palmitoyl-Lys-Thr-Thr-Lys-Ser, MW 802.06 g/mol) is a collagen-stimulating lipopeptide derived from the pro-collagen I C-terminal propeptide sequence, studied in dermal fibroblast cell models for extracellular matrix synthesis pathway research. It is supplied as a lyophilised powder in a 10mL sterile glass vial containing 10mg. The palmitoyl modification requires ethanol co-solvent for complete aqueous reconstitution.

Materials Required

  • Palmitoyl Pentapeptide-4 10mg lyophilised vial
  • Sterile ethanol (96%) for initial dissolution
  • Bacteriostatic water (BAC water) for dilution to final volume
  • 1mL or 2mL sterile syringe with needle
  • Alcohol swabs (70% isopropyl)
  • Nitrile gloves
  • Permanent marker for labelling

Pre-Reconstitution Preparation

Inspect the vial for intact lyophilised powder and unbroken seal. Allow to equilibrate to room temperature for 15 minutes. Pal-KTTKS contains the KTTKS procollagen sequence with N-terminal palmitoyl modification — the combination of hydrophilic peptide core and hydrophobic fatty chain creates an amphiphilic structure that benefits from ethanol pre-wetting before aqueous dilution.

Step-by-Step Reconstitution Protocol

Step 1 — Prepare workspace. Clean work surface with 70% isopropyl alcohol. Allow to dry. Wear nitrile gloves throughout.

Step 2 — Swab vial stopper. Clean the rubber stopper with a fresh alcohol swab. Air dry 10 seconds.

Step 3 — Pre-wet with sterile ethanol. Inject 0.2mL of sterile 96% ethanol slowly down the inner glass wall. Swirl gently for 15 seconds to pre-dissolve the lipophilic palmitoyl portion.

Step 4 — Add BAC water. Slowly add 1.8mL of BAC water along the inner wall (2mL total). Swirl gently for 30–60 seconds. Pal-KTTKS should dissolve into a clear to slightly opalescent solution.

Step 5 — Inspect and label. Confirm solution clarity. Label with date, solvent composition, concentration, and initials.

Resulting Concentration

Adding 2mL total solvent (10% EtOH/BAC water) to a 10mg Pal-Penta-4 vial yields a stock concentration of 5mg/mL. For collagen synthesis and ECM pathway assays in NHDFa or HDF cell model preparations, working concentrations of 1ng/mL to 100mcg/mL are prepared by serial dilution into serum-free media with matched vehicle controls.

Concentration Reference Table

Total VolumeEtOH:BAC ratioConcentration
1mL0.1mL:0.9mL10.0mg/mL
2mL0.2mL:1.8mL5.0mg/mL
4mL0.4mL:3.6mL2.5mg/mL

Storage Conditions and Stability

Store lyophilised Pal-Penta-4 at −20°C prior to reconstitution, protected from light and moisture. Once reconstituted in 10% EtOH/BAC water, store at 2–8°C for up to 14 days. Prepare working aliquots in single-use volumes and store at −80°C for long-term storage. The KTTKS peptide core is stable at physiological pH — the palmitoyl ester bond is hydrolytically stable under standard refrigeration conditions.

Troubleshooting Common Reconstitution Issues

Powder not dissolving: Gently tilt and swirl to bring undissolved powder into contact with solvent. Do not heat. If incomplete after 60 seconds, inspect for moisture ingress or compromised seal.

Cloudy solution: Cloudiness may indicate aggregation or contamination. Discard if cloudiness persists after gentle swirling.

Foaming: Allow to settle naturally. Reduce injection speed on subsequent attempts and ensure stream is directed along the glass wall.

Loss of material: Swirl to contact all inner surfaces. Invert and draw from the stopper end for maximum recovery.

Research Application Notes

Palmitoyl Pentapeptide-4 is the most extensively studied cosmetic research peptide in the collagen-stimulating category. Its KTTKS core sequence was identified from the pro-collagen I C-propeptide region and acts as a signalling peptide that modulates fibroblast ECM synthesis pathway activity. In NHDFa cell model research, standard endpoints include COL1A1 and COL3A1 mRNA expression by RT-qPCR, procollagen type I secretion by ELISA in conditioned media, and fibronectin expression by immunofluorescence. For comparative palmitoyl peptide studies alongside PAL-GHK and Pal-Tetra-7, prepare matched stock concentrations accounting for molecular weight differences to ensure equimolar comparisons. Palmitoyl Pentapeptide-4 10mg vials are available from Pinnacle Peptides, verified at ≥99% purity by HPLC and mass spectrometry.

All content is intended for in vitro laboratory research purposes only. Not for human or animal consumption. Not intended to diagnose, treat, cure, or prevent any condition.